Pharmacy alumni and faculty work with research team to develop North America’s first test to predict Kawasaki disease

Pharmacy alumni and faculty work with research team to develop North America’s first test to predict Kawasaki disease

A new tool under development by University at Buffalo researchers could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States.

The new tool – described in a study published earlier this year in the Journal of Pediatric Pharmacology and Therapeutics – lays the groundwork for North America’s first test to predict resistance to therapeutic treatments for the rare disease, but severe inflammatory disease.

READ MORE>>